Kenneth Pienta Insider Profile
4 Followers
Kenneth Pienta, CMO at Cue Biopharma, holds 2.00K shares in Cue Biopharma (Ticker: CUE), holds 30.00K shares in Curis (Ticker: CRIS).
Kenneth Pienta's Trading History
You May Also Like
Kenneth Pienta insider profile FAQ
What is the percentage of profitable transactions made by Kenneth Pienta?
The percentage of profitable transactions made by Kenneth Pienta is 0%.
What is the average return per transaction made by Kenneth Pienta?
The average return per transaction made by Kenneth Pienta is -47.80%.
What stocks does Kenneth Pienta hold?
Kenneth Pienta holds: CUE, CRIS stocks.
What was Kenneth Pienta’s latest transaction?
Kenneth Pienta’s latest transaction was an Uninformative Buy of $67.19K.
What was Kenneth Pienta's most profitable transaction?
Kenneth Pienta’s most profitable transaction was an Informative Buy of CUE stock on January 22, 2021. The return on the trade was -36.00%.
What is Kenneth Pienta's role in Cue Biopharma?
Kenneth Pienta's role in Cue Biopharma is CMO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
